Merck & Company, Inc.

    MRK ·NYSE ·Pharmaceutical Preparations ·Inc. in NJ
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-05-02 10-Q expected by 2026-05-07 (in 1 day)
    • ~2026-08-05 10-Q expected by 2026-08-10 (in 96 days)
    • ~2026-11-05 10-Q expected by 2026-11-10 (in 188 days)
    • ~2027-02-24 10-K expected by 2027-02-28 (in 299 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-30 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-04-08 DEF 14A Proxy Statement
    • 2026-04-07 SC TO-T SC TO-T
    • 2026-02-24 10-K Annual Report
    • 2026-02-03 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-12-04 8-K Other Events; Financial Statements and Exhibits
    • 2025-11-05 10-Q Quarterly Report
    • 2025-10-30 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-09-09 8-K Other Events; Financial Statements and Exhibits
    • 2025-08-05 10-Q Quarterly Report
    • 2025-07-29 8-K Earnings Release; Costs Associated with Exit; Financial Statements and Exhibits
    • 2025-05-02 10-Q Quarterly Report
    • 2025-04-24 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-02-25 10-K Annual Report
    • 2025-02-04 8-K Earnings Release; Financial Statements and Exhibits